A vitronectin M381T polymorphism increases risk of hemangioblastoma in patients with VHL gene defect

Journal of Molecular Medicine

Volumn 87, Issue 6, 2009, Pages 613-622

  Huang, Jing Shan ^a,b   Lin, Chih Ming ^a,b   Cheng, Yu Che ^a   Hung, Kun Long ^a,b   Chien, Chih Cheng ^a,b   Chen, Shao Kuan ^a   Chang, Chih Ju ^a   Chen, Chan Wei ^a   Huang, Chi Jung ^a,b,c  

^a CATHAY GENERAL HOSPITAL   (Taiwan)

^b FU JEN CATHOLIC UNIVERSITY   (Taiwan)

^c NATIONAL DEFENSE MEDICAL CENTER   (Taiwan)

Author keywords

Brain; Clinical research; Genomics; Molecular genetics; Polymorphism; Proteome

Indexed keywords

VITRONECTIN;

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER RISK; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENE; GENE MUTATION; GENETIC RISK; GENOMICS; HEMANGIOBLASTOMA; HUMAN; MALE; NUCLEOTIDE SEQUENCE; PEDIGREE; PROTEOMICS; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SINGLE STRAND CONFORMATION POLYMORPHISM; VHL GENE;

ADULT; CEREBELLAR NEOPLASMS; FEMALE; GENOTYPE; HEMANGIOBLASTOMA; HUMANS; MALE; MIDDLE AGED; MUTATION; PEDIGREE; POLYMORPHISM, GENETIC; VITRONECTIN; VON HIPPEL-LINDAU DISEASE; VON HIPPEL-LINDAU TUMOR SUPPRESSOR PROTEIN;

EID: 67349089076     PISSN: 09462716     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00109-009-0456-1     Document Type: Article

References (52)

1. RR Lonser EH Oldfield 2006 Spinal cord hemangioblastomas Neurosurg Clin N Am 17 37 44 (Pubitemid 43163205)
2. TR Browne RD Adams GH Roberson 1976 Hemangioblastoma of the spinal cord. Review and report of five cases Arch Neurol 33 435 441
3. AO Vortmeyer Q Yuan YS Lee Z Zhuang EH Oldfield 2004 Developmental effects of von Hippel-Lindau gene deficiency Ann Neurol 55 721 728 (Pubitemid 38544333)
4. SD Chang JA Meisel SL Hancock DP Martin M McManus JRJ Adler 1998 Treatment of hemangioblastomas in von Hippel-Lindau disease with linear accelerator-based radiosurgery Neurosurgery 43 28 34
5. G Ertas MB Altundag AR Ucer F Cankal K Altundag 2005 Treatment of recurrent cerebellar hemangioblastoma with external radiotherapy in a patient with von Hippel-Lindau disease: a case report and review of the literature J Neurooncol 73 273 275 (Pubitemid 40974025)
6. BM Shehata CA Stockwell AA Castellano-Sanchez S Setzer CL Schmotzer H Robinson 2008 Von Hippel-Lindau (VHL) disease: an update on the clinico-pathologic and genetic aspects Adv Anat Pathol 15 165 171
7. JY Lee SM Dong WS Park NJ Yoo CS Kim JJ Jang JG Chi B Zbar IA Lubensky WM Linehan AO Vortmeyer Z Zhuang 1998 Loss of heterozygosity and somatic mutations of the VHL tumor suppressor gene in sporadic cerebellar hemangioblastomas Cancer Res 58 504 508 (Pubitemid 28087414)
8. K Hattori J Teranishi C Stolle M Yoshida K Kondo T Kishida H Kanno M Baba Y Kubota M Yao 2006 Detection of germline deletions using real-time quantitative polymerase chain reaction in Japanese patients with von Hippel-Lindau disease Cancer Sci 97 400 405
9. JS Huang CJ Huang SK Chen CC Chien CW Chen L CM 2007 Associations between VHL genotype and clinical phenotype in familial von Hippel-Lindau disease Eur J Clin Invest 37 492 500 (Pubitemid 46817343)
10. SA Adams DA Hilton 2002 Recurrent haemangioblastoma with glial differentiation Neuropathol Appl Neurobiol 28 142 146 (Pubitemid 34415733)
11. BU Bender M Gutsche S Glasker B Muller G Kirste C Eng HP Neumann 2000 Differential genetic alterations in von Hippel-Lindau syndrome-associated and sporadic pheochromocytomas J Clin Endocrinol Metab 85 4568 4574 (Pubitemid 32157635)
12. F Latif K Tory J Gnarra M Tao FM Duh ML Orcutt T Stackhouse I Kuzmin W Modi L Geil 1993 Identification of the von Hippel-Lindau disease tumor suppressor gene Science 260 1317 1320
13. O Carrette PR Burkhard JC Sanchez DF Hochstrasser 2006 State-of-the-art two-dimensional gel electrophoresis: a key tool of proteomics research Nat Protoc 1 812 823
14. FW Khwaja JS Duke-Cohan DJ Brat EG Van Meir 2006 Attractin is elevated in the cerebrospinal fluid of patients with malignant astrocytoma and mediates glioma cell migration Clin Cancer Res 12 6331 6336 (Pubitemid 44799701)
15. YG Tsay YH Wang CM Chiu BJ Shen SC Lee 2000 A strategy for identification and quantitation of phosphopeptides by liquid chromatography/tandem mass spectrometry Anal Biochem 287 55 64
16. JRr Yates JK Eng AL McCormack D Schieltz 1995 Method to correlate tandem mass spectra of modified peptides to amino acid sequences in the protein database Anal Chem 67 1426 1436
17. RA Craven S Hanrahan N Totty P Harnden AJ Stanley ER Maher AL Harris WS Trimble PJ Selby RE Banks 2006 Proteomic identification of a role for the von Hippel Lindau tumour suppressor in changes in the expression of mitochondrial proteins and septin 2 in renal cell carcinoma Proteomics 6 3880 3893 (Pubitemid 44065165)
18. MP van Goor EB Gómez-García FW Leebeek GJ Brouwers PJ Koudstaal DW Dippel 2005 The -148 C/T fibrinogen gene polymorphism and fibrinogen levels in ischaemic stroke: a case-control study J Neurol Neurosurg Psychiatry 76 121 123 (Pubitemid 40013505)
19. G Chambers L Lawrie P Cash GI Murray 2000 Proteomics: a new approach to the study of disease J Pathol 192 280 288
20. MA Smith SK Bains JC Betts EH Choy ED Zanders 2001 Use of two-dimensional gel electrophoresis to measure changes in synovial fluid proteins from patients with rheumatoid arthritis treated with antibody to CD4 Clin Diagn Lab Immunol 8 105 111 (Pubitemid 32061691)
21. PL Choyke GM Glenn MM Walther NJ Patronas WM Linehan B Zbar 1995 von Hippel-Lindau disease: genetic, clinical, and imaging features Radiology 194 629 642
22. HJ Decker EJ Weidt J Brieger 1997 The von Hippel-Landau tumor suppressor gene. A rare and intriguing disease opening new insight into basic mechanisms of carcinogenesis Cancer Genet Cytogenet 93 74 83 (Pubitemid 27102492)
23. E Liu MJ Percy CI Amos Y Guan S Shete DW Stockton MF McMullin LA Polyakova SO Ang YD Pastore K Jedlickova TR Lappin V Gordeuk JT Prchal 2004 The worldwide distribution of the VHL 598C∈>∈T mutation indicates a single founding event Blood 103 1937 1940 (Pubitemid 38268995)
24. CA Friedrich 2001 Genotype-phenotype correlation in von Hippel-Lindau syndrome Hum Mol Genet 10 763 767 (Pubitemid 32331586)
25. WM Linehan MM Walther B Zbar 2003 The genetic basis of cancer of the kidney J Urol 170 2163 2172 (Pubitemid 37413950)
26. SD Wait AO Vortmeyer RR Lonser DT Chang MA Finn DA Bhowmick SD Pack EH Oldfield Z Zhuang 2004 Somatic mutations in VHL germline deletion kindred correlate with mild phenotype Ann Neurol 55 236 240 (Pubitemid 38167000)
27. YR Huang J Zhang JD Wang XD Fan 2004 Genetic study of a large Chinese kindred with von Hippel-Lindau disease Chin Med J (Engl) 117 552 557 (Pubitemid 38579075)
28. H Dollfus P Massin P Taupin C Nemeth S Amara S Giraud C Béroud P Dureau A Gaudric P Landais S Richard 2002 Retinal hemangioblastoma in von Hippel-Lindau disease: a clinical and molecular study Invest Ophthalmol Vis Sci 43 3067 3074 (Pubitemid 34977061)
29. M Miyagami Y Katayama 2004 Long-term prognosis of hemangioblastomas of the central nervous system: clinical and immunohistochemical study in relation to recurrence Brain Tumor Pathol 21 75 82 (Pubitemid 39518150)
30. B Dahlback ER Podack 1985 Characterization of human S protein, an inhibitor of the membrane attack complex of complement. Demonstration of a free reactive thiol group Biochemistry 24 2368 2374 (Pubitemid 15009492)
31. S Gläsker A Berlis A Pagenstecher VI Vougioukas V Van Velthoven 2005 Characterization of hemangioblastomas of spinal nerves Neurosurgery 56 503 509
32. WY Kim WG Kaelin 2004 Role of VHL gene mutation in human cancer J Clin Oncol 22 4991 5004 (Pubitemid 46646218)
33. G Schuch M de Wit J Höltje E Laack G Schilling DK Hossfeld W Fiedler P Scigalla MS Jacobs 2005 Case 2. Hemangioblastomas: diagnosis of von Hippel-Lindau disease and antiangiogenic treatment with SU5416 J Clin Oncol 23 3624 3626
34. DM Tollefsen CJ Weigel MH Kabeer 1990 The presence of methionine or threonine at position 381 in vitronectin is correlated with proteolytic cleavage at arginine 379 J Biol Chem 265 9778 9781
35. D Chain B Korc-Grodzicki T Kreizman S Shaltiel 1990 The phosphorylation of the two-chain form of vitronectin by protein kinase A is heparin dependent FEBS Lett 269 221 225 (Pubitemid 20245357)
36. D Chain B Korc-Grodzicki T Kreizman S Shaltiel 1991 Endogenous cleavage of the Arg-379-Ala-380 bond in vitronectin results in a distinct conformational change which 'buries' Ser-378, its site of phosphorylation by protein kinase A Biochem J 274 387 394
37. SM Ribeiro S Schultz-Cherry JE Murphy-Ullrich 1995 Heparin-binding vitronectin up-regulates latent TGF-beta production by bovine aortic endothelial cells J Cell Sci 108 1553 1561
38. M Yi T Sakai R Fassler E Ruoslahti 2003 Antiangiogenic proteins require plasma fibronectin or vitronectin for in vivo activity Proc Natl Acad Sci U S A 100 11435 11438 (Pubitemid 37205953)
39. DW Barnes J Silnutzer C See M Shaffer 1983 Characterization of human serum spreading factor with monoclonal antibody Proc Natl Acad Sci U S A 80 1362 1366
40. D Parker K Ferreri T Nakajima VJ LaMorte R Evans SC Koerber C Hoeger MR Montminy 1996 Phosphorylation of CREB at Ser-133 induces complex formation with CREB-binding protein via a direct mechanism Mol Cell Biol 16 694 703
41. S Pons JL Trejo JR Martinez-Morales E Marti 2001 Vitronectin regulates Sonic hedgehog activity during cerebellum development through CREB phosphorylation Development 128 1481 1492 (Pubitemid 32514833)
42. ME Cockman N Masson DR Mole P Jaakkola GW Chang SC Clifford ER Maher CW Pugh PJ Ratcliffe PH Maxwell 2000 Hypoxia inducible factor-alpha binding and ubiquitylation by the von Hippel-Lindau tumor suppressor protein J Biol Chem 275 25733 25741
43. JL Ruas L Poellinger T Pereira 2005 Role of CBP in regulating HIF-1-mediated activation of transcription J Cell Sci 118 301 311 (Pubitemid 40277343)
44. HA Kenny S Kaur LM Coussens E Lengyel 2008 The initial steps of ovarian cancer cell metastasis are mediated by MMP-2 cleavage of vitronectin and fibronectin J Clin Invest 118 1367 1379
45. C Cybulski K Krzystolik A Murgia B Gorski T Debniak A Jakubowska M Martella G Kurzawski M Prost I Kojder J Limon P Nowacki L Sagan B Bialas J Kaluza M Zdunek A Omulecka D Jaskolski E Kostyk B Koraszewska-Matuszewska O Haus H Janiszewska K Pecold M Starzycka R Slomski M Cwirko A Sikorski B Gliniewicz L Cyrylowski L Fiszer-Maliszewska J Gronwald A Toloczko-Grabarek S Zajaczek J Lubinski 2002 Germline mutations in the von Hippel-Lindau (VHL) gene in patients from Poland: disease presentation in patients with deletions of the entire VHL gene J Med Genet 39 E38
46. S Glasker BU Bender TW Apel V van Velthoven LM Mulligan J Zentner HP Neumann 2001 Reconsideration of biallelic inactivation of the VHL tumour suppressor gene in hemangioblastomas of the central nervous system J Neurol Neurosurg Psychiatry 70 644 648 (Pubitemid 32398001)
47. SH Sprenger JM Gijtenbeek P Wesseling R Sciot F van Calenbergh M Lammens JW Jeuken 2001 Characteristic chromosomal aberrations in sporadic cerebellar hemangioblastomas revealed by comparative genomic hybridization J Neurooncol 52 241 247 (Pubitemid 33638523)
48. T Shuin I Yamazaki K Tamura M Kamada S Ashida 2004 Recent advances in ideas on the molecular pathology and clinical aspects of Von Hippel-Lindau disease Int J Clin Oncol 9 283 287 (Pubitemid 39277923)
49. C Beroud D Joly C Gallou F Staroz MT Orfanelli C Junien 1998 Software and database for the analysis of mutations in the VHL gene Nucleic Acids Res 26 256 258 (Pubitemid 28295283)
50. AR Webster FM Richards FE MacRonald AT Moore ER Maher 1998 An analysis of phenotypic variation in the familial cancer syndrome von Hippel-Lindau disease: evidence for modifier effects Am J Hum Genet 63 1025 1035 (Pubitemid 30418572)
51. K Minamiguchi H Kumagai T Masuda M Kawada M Ishizuka T Takeuchi 2001 Thiolutin, an inhibitor of HUVEC adhesion to vitronectin, reduces paxillin in HUVECs and suppresses tumor cell-induced angiogenesis Int J Cancer 93 307 316 (Pubitemid 32592047)
52. M Yi E Ruoslahti 2001 A fibronectin fragment inhibits tumor growth, angiogenesis, and metastasis Proc Natl Acad Sci U S A 98 620 624 (Pubitemid 32105092)